NanoVibronix appoints Doron Besser as CEO; Brian Murphy retires but stays on board

ENvue Medical, Inc.

Brian Murphy retired as CEO of NanoVibronix effective June 4, 2025, and will remain as a director.
Doron Besser, previously CEO of subsidiary ENvue Medical Holdings, appointed as CEO effective same date.
NanoVibronix completed acquisition of ENvue on February 14, 2025, creating a combined growth platform.
Besser has a medical device background; previously helped lead superDimension, acquired by Covidien for ~$300M.
Board Chairman Christopher Fashek thanked Murphy and expressed confidence in Besser's leadership.

item 5.02item 8.01item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Doron Besser

Chief Executive Officer

FEED · ENvue Medical, Inc.

Effective: 2025-06-04
Filed: Jun 04, 2025 23:59 UTC

the Board of Directors (the “ Board ”) of NanoVibronix, Inc. (the “ Company ”) appointed Doron Besser, M.D., a director of the Board and Chief Executive Officer and President of the Company’s wholly-owned subsidiary, ENvue Medical Holdings LLC (“ ENvue ”), as the Company’s Chief Executive Officer (“ CEO ”), effective as of the same date

Departed

Brian Murphy

Chief Executive Officer

FEED · ENvue Medical, Inc.

Effective: 2025-06-04
Successor: Doron Besser
Filed: Jun 04, 2025 23:59 UTC

Brian Murphy resigned from the Company as its CEO due to Mr. Murphy’s retirement, effective as of the same date.

Source: SEC EDGAR

accession 0001641172-25-013620

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.